<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="225">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01368133</url>
  </required_header>
  <id_info>
    <org_study_id>2010M-010</org_study_id>
    <nct_id>NCT01368133</nct_id>
  </id_info>
  <brief_title>The Observational Study of Growth Hormone-secreting Pituitary Tumors</brief_title>
  <official_title>The Observational Study of the Structures and Functions of Multiple Organs in Patients With Growth Hormone-secreting Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Natural Science Foundation of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Huashan Hospital</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The major purpose of this study is to evaluate the changes of multiple organs in patients
      with growth hormone-secreting pituitary tumors before and after surgery. Plasma, DNA samples
      and pituitary tumor tissues will be kept for further analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multiple organs or systems will be affected by excessive growth hormones in patients with
      acromegaly. The major purpose of this study is to evaluate the changes before and after the
      pituitary surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acromegaly</condition>
  <condition>Pituitary Tumor</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, DNA and pituitary tumor tissues
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The acromegaly patients at Huashan Hospital will be recruited anf followed up prior to
        surgery and one month, 3 months, 6 months and 12 months after surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of acromegaly

          -  &gt; 18 years old
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yao Zhao, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huashan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiahui Qiu, M.D.</last_name>
    <phone>86-13585951850</phone>
    <email>qiuhuijiaatsjtu@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>zhaoyun zhang, M.D.</last_name>
    <phone>86-21-52888286</phone>
    <email>zhaoyunzhang@fudan.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Huashan Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cuiyun Wu</last_name>
      <phone>86-21-52888047</phone>
      <email>hskyc@fudan.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Zhaoyun Zhang</last_name>
      <phone>86-21-52888286</phone>
      <email>zhaoyunzhang@fudan.edu.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Yao Zhao, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 24, 2013</lastchanged_date>
  <firstreceived_date>June 6, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huashan Hospital</investigator_affiliation>
    <investigator_full_name>Zhaoyun Zhang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>acromegaly</keyword>
  <keyword>pituitary tumor</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acromegaly</mesh_term>
    <mesh_term>Pituitary Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
